Although previous studies revealed Olig2 expression is normally restricted to neural tissues [18], recent findings show that Olig2 is overexpressed in a wide range of cancers including melanoma, non-small lung carcinoma, leukemia, and breast cancers which suggested overexpression of Olig2 might be oncogenic [19]. This evidence concerns the gene OLIG2 and breast cancer.